Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma
- PMID: 28778323
- DOI: 10.1016/j.vetimm.2017.07.001
Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma
Abstract
Although tumor-infiltrating lymphocytes (TILs) play a key role in anti-tumor immunity, their involvement in canine transitional cell carcinoma (TCC) is not well-documented. The objective of this study was to investigate the association between TIL number and prognosis in dogs with urinary bladder TCC. Immunohistochemical analysis of CD3 and granzyme B was performed using canine TCC (n=32) and normal bladder (n=10) tissues. The numbers of CD3+ and granzyme B+ cells located in peritumoral stroma of canine TCC were significantly higher than those in normal controls. In TCC cases, the number of CD3+ TILs was not significantly related to prognosis, whereas the abundant granzyme B+ TILs were associated with favorable outcome. Since granzyme B+ TILs were not associated with the tumor stage, the presence of granzyme B+ TILs may be an independent prognostic factor. These results suggest that granzyme B+ TILs play a role in anti-tumor immunity and inhibit tumor progression in canine TCC.
Keywords: Anti-tumor immunity; Canine; Tumor-infiltrating lymphocytes; Urinary bladder; Urothelial carcinoma.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.J Urol. 2015 Aug;194(2):556-62. doi: 10.1016/j.juro.2015.02.2941. Epub 2015 Mar 6. J Urol. 2015. PMID: 25752441
-
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.Am J Vet Res. 2003 Aug;64(8):1017-20. doi: 10.2460/ajvr.2003.64.1017. Am J Vet Res. 2003. PMID: 12926595
-
Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).J Am Vet Med Assoc. 2011 Aug 1;239(3):350-6. doi: 10.2460/javma.239.3.350. J Am Vet Med Assoc. 2011. PMID: 21801049
-
Management of transitional cell carcinoma of the urinary bladder in dogs: a review.Vet J. 2015 Aug;205(2):217-25. doi: 10.1016/j.tvjl.2015.01.017. Epub 2015 Jan 26. Vet J. 2015. PMID: 25747698 Review.
-
Management of transitional cell carcinoma.Vet Clin North Am Small Anim Pract. 2003 May;33(3):597-613. doi: 10.1016/s0195-5616(03)00032-9. Vet Clin North Am Small Anim Pract. 2003. PMID: 12852238 Review.
Cited by
-
Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.Vet Sci. 2022 Feb 28;9(3):107. doi: 10.3390/vetsci9030107. Vet Sci. 2022. PMID: 35324835 Free PMC article. Review.
-
Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy.Cancers (Basel). 2022 Oct 13;14(20):5008. doi: 10.3390/cancers14205008. Cancers (Basel). 2022. PMID: 36291791 Free PMC article. Review.
-
Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells.PLoS One. 2019 Jun 17;14(6):e0218382. doi: 10.1371/journal.pone.0218382. eCollection 2019. PLoS One. 2019. PMID: 31206526 Free PMC article.
-
Tumor-Infiltrating Lymphocytes and Neutrophils and Their Location in Canine Mammary Neoplasms with a Solid Arrangement: A Prognostic Factor?Animals (Basel). 2025 Jan 20;15(2):287. doi: 10.3390/ani15020287. Animals (Basel). 2025. PMID: 39858287 Free PMC article.
-
Exploring the association of intratumoral immune cell infiltrates with histopathologic grade in canine mast cell tumors.Res Vet Sci. 2022 Oct;147:83-91. doi: 10.1016/j.rvsc.2022.04.005. Epub 2022 Apr 22. Res Vet Sci. 2022. PMID: 35490489 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical